Jill Leversage, Director at Aurinia Pharmaceuticals Inc. (AUPH), bought 400 shares at $16.03 ($6K) on 2021-01-29, disclosed to the SEC on 2021-02-02.
Open-market purchase of $6k AUPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| AUPH | BUY | 2021-12-15 | $32K | — | Filing → |
| AUPH | BUY | 2021-05-12 | $27K | — | Filing → |